Clinical Research Directory
Browse clinical research sites, groups, and studies.
BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis
Sponsor: Howard University
Summary
This study evaluates the feasibility and acceptability of BRAVE, a manualized cognitive behavioral therapy (CBT)-based intervention designed to address dynamic risk factors for violence among young adults with early psychosis. Using a stepped-wedge randomized design, all participants will receive treatment as usual followed by the BRAVE intervention. The study will also explore changes in violence-related behaviors and treatment engagement over time.
Official title: Young Adults and Violent Behavior During Early Psychosis (Aim 3)
Key Details
Gender
All
Age Range
18 Years - 30 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2026-02-16
Completion Date
2026-08
Last Updated
2026-02-18
Healthy Volunteers
No
Conditions
Interventions
BRAVE (Behavioral Response Against Violence Engagement)
BRAVE is a brief, manualized cognitive behavioral therapy (CBT)-based behavioral intervention designed to address modifiable risk factors associated with violence risk among young adults with early psychosis. The intervention is delivered as weekly sessions within early psychosis services and focuses on enhancing treatment engagement, emotional regulation, cognitive flexibility, and behavioral coping strategies related to aggression and violence risk. Participants continue to receive treatment as usual throughout the study.
Treatment As Usual (TAU)
Treatment as usual consists of routine outpatient clinical care provided by early psychosis services, including psychiatric medication management and psychosocial services, as determined by the treating clinical team. No study-specific intervention is delivered during this condition.
Locations (1)
Howard University Hospital
Washington D.C., District of Columbia, United States